Introduction
This review highlights some of the more important advances that have been made in renal physiology, nephrology and renal replacement therapy. There have been dramatic advances in our understanding of the molecular mechanisms in physiology, pathology and in the pharmacology ofimmunosuppression. We understand better the factors that lead to the relentless progression to end stage renal failure in conditions where the original or specific disease may well be inactive. Intervention is now possible to slow progression.
Long term dialysis has produced its own special problems and increased ingenuity and improved biotechnology are required. The revolution occurring in genetic engineering is paying its dividends to the dialysis populations through the remarkable benefits of human recombinant erythropoietin. The elusive goal of transplantation without infection or rejection remains a distant objective but developments in monoclonal antibody production and the early claims for FK506 are rapidly being put to the test.
Renal physiology (A) Tubularfunction (i) Tubular transport mechanisms
The concept of membrane cotransport is almost 30 years old.' The process is now considered to be virtually ubiquitous. 'There are no primary active transport processes but for some cations. Other accumulative transport is always secondary active via co-transport with sodium (and/or countertransport with potassium)'.2 These remarks conclude the introduction to a symposium on the subject (Cotransport mechanisms in renal tubules, 1989),7-which reviews recent developments in the sodium-coupled transport of glucose, amino acids, phosphate, and organic anions. Urate transport (coupled only indirectly to sodium via urate-anion counterexchangers), chloride-bicarbonate exchangers (there are separate sodium-dependent and sodiumindependent systems and bicarbonate may also be cotransported electrogenically with sodium), the basolateral potassium-chloride cotransporter, and Na+:K+:2ClI cotransport in the thick ascending limb are among other topics addressed. Most notably, the DNA for the intestinal Na+-glucose carrier has been cloned and sequenced,3'4 a chloride-formate exchanger may play a major role in electroneutral sodium chloride reabsorption in the proximal tubule,' and thiazide-sensitive sodium chloride cotransport has been confirmed in the early distal tubule. 6 The different segments of the nephron have their particular transporting properties by virtue of the specific transporter proteins, active ion pumps and channels that are distributed in a highly organized system in membranes of the tubular cells. The system works to transport specific substances from either the luminal fluid or the capillary as these transporting mechanisms are asymmetrically orientated with fixed differences between the luminal membrane and the basolateral membranes. The movement of molecules is down electrochemical gradients generated by the ubiquitous 3Na+/2K+ -ATPase pump located in the basolateral membrane. Figures 1 to 6 summarize the current view on the distribution of these transporter functions in different segments of the nephron.
There has been some debate on the relative importance of kidney and liver in systemic acidbase balance.7'8 The cellular and molecular aspects of renal hydrogen ion transport have been reviewed,9 and the role of proton pumps emphasized.'0 An interesting concept of the kidney's role in acid-base balance has emerged. In order to achieve acid-base balance the kidney must synthesize ' Cl' which has been consumed in the buffering process. A minority of 'new' bicarbonate is formed by the titration of hydrogen ions with filtered HP042-in the tubular fluid. The majority is formed by the metabolism of glutamine (an organic anion whose production does not also yield protons) to NH4' and bicarbonate in proximal tubular cells. Excretion of this NH4+ (via the Na'-NH4' antiporter) is a necessary step to ensure net gain of bicarbonate since, if retained, NH4+ is converted by the liver to urea, a process which consumes bicarbonate. In this view the renal ammonium system is critically involved in the generation of 'new bicarbonate'. Proton secretion whilst essential to maintain acidbase balance is essentially involved in reclamation and recycling of tubular bicarbonate."
The renal ammonium system is thought to play an important role in the response to chronic metabolic acidosis in some situations including chronic renal failure,'2 and increased concentrations of ammonia are found in the renal cortex of the remnant kidney.'3 There is some evidence that this may have a role in the progression of renal failure possibly by activation of the alternative complement pathway. '4 The renal handling of calcium has been reexamined. ' Levi.'7 The genetic defect in the commonest of these disorders, Xlinked hypophosphataemic rickets, has recently been localized to the Xp22 chromosomal band. '8 Furthermore, in the murine counterpart of this disease recent work with parabiosis suggests that a humoral factor which is distinct from parathyroid hormone may be associated with the defect in renal tubular phosphate reabsorption.'9 A large series of patients with Bartter's syndrome with a 10 year follow-up has been reported emphasizing its essentially benign nature.20 Most patients presented with incidentally discovered hypokalaemia which was rarely fully correctable by treatment. Another report2l draws attention to the high prevalence of nephrocalcinosis in Bartter's syndrome.
(iii) Hormones and tubularfunction (a) Aldosterone It is now well established that the antinatriuretic and kaliuretic actions of aldo-sterone are principally centred on the distal tubule and cortical collecting duct. There is much uncertainty though about its actions at the cellular and molecular levels. A two-step mechanism of action via early and late aldosterone-induced proteins (AIPs) has recently been suggested.22 At 1-3 hours after aldosterone application early AlPs are formed which may include the enzymes methionine adenosyltransferase and S-adenosylhomocysteinetransferase. These enzymes cause an increase in the intracellular S-adenosylmethionine level which may in turn be responsible for the increased activity ofmethyltransferases. Increased methylation ofthe protein moiety of the sodium channels in the apical membrane causes an influx of sodium. The resulting increase in intracellular sodium causes increased activity of pre-existing Na/K-ATPase in the basolateral membrane, with increased sodium output. At 4-24 hours, aldosterone increases the synthesis of late AlPs including newly synthesized subunits of Na/K-ATPase which are duly integrated into the basolateral membrane. That there are two aldosterone receptors with different affinities may support this concept, though early AlPs could activate other genes coding for late AlPs.
(b) Natriuretic hormones This has been an area of intense activity, and a vast amount ofdata has been accumulated and subjected to critical review.23 25 Most attention has been directed at the recently discovered atrial natriuretic peptide (ANP) but there are many other contenders for the title of natriuretic hormone. These include one or more endogenous digitalis-like compounds, circulating lysophospholipids, and gamma-melanocyte-stimulating hormone, which has recently been discovered to be responsible for the natriuresis which immediately follows unilateral nephrectomy in the rat. 26 ANP undoubtedly has potent natriuretic properties which derive from a variety of systemic and intrarenal effects (Table I) . Nevertheless its precise physiological and pathophysiological role remains unclear. It conditions the resistor segments of the renal vascular tree maintain a spontaneous resting tone which is susceptible to a degree of modulation by, but is not regulated by, vasoactive hormones. The net effect of the 'hormonal soup' to which the system is exposed is to stabilize it rather than control it. Hence inhibition of one of these hormonal systems does not vary the resistance but may impair its response to perturbations by some other mechanism (such as the effect of non steroidal anti-inflammatory agents on renal haemodynamics in conditions of volume depletion). The model considers the renal resistance system to be composed of three discrete components, a preglomerular myogenically regulated system, a TGFcontrolled system localized at the preglomerular vascular pole, and immediately downstream from the former. 228 cases of ARF according to the presence or absence of 4 variables (oliguria, assisted respiration, hypotension, and coma) when the patient was first seen. There were no survivors from among the 22 patients with discriminant scores of > 0.856. The urgent need for more such studies has been emphasized. 49 The prognosis for renal function in survivors has also been addressed. Glomerular filtration rate, and tubular handling of sodium, glucose, phosphate and amino acids were normal in all 10 patients tested 7-12 years following an episode of ARF in childhood. Filtration fraction though was elevated in 6 of 8 patients, testifying to abnormal glomerular haemodynamics, a consequence perhaps of previous nephron loss. 50 (ii) Causes (a) Aminoglycoside nephrotoxicity ARF is frequently multifactorial and in the general hospital setting, drugs, particularly aminoglycoside antibiotics, and radiographic contrast agents, have frequently been incriminated. Gentamicin chronically infused into rats in doses low enough to maintain plasma levels at less than the generally acceptable trough levels or even in the undetectable range, caused a gradual decrement in inulin clearance to 50% of control levels by 6 months and a chronic interstitial nephritis.5' Interestingly both renal function and histology continued to progressively decline after cessation of treatment. These observations and the marked dissociation between inulin and creatinine clearances noted during the study, question the generally accepted monitoring standards. 52 The development of rapid assays of urinary peptide level or brush border antigen are advocated as sensitive indicators of nephrotoxicity.53 It is also worth a thought that gentamicin nephrotoxicity has been shown to be potentiated by a focus of tissue necrosis.5 (b) X-ray contrast nephrotoxicity There have been two prospective controlled studies on the effects of contrast agents on renal function. Diabetics with pre-existing renal insufficiency were confirmed to be at significant risk of clinically important contrast-induced nephropathy (50% increment in serum creatinine), though the incidence was less than previously reported at about 9%.55 Non-diabetics with renal insufficiency had less risk (5.5%) of milder deterioration (25% increment in serum creatinine). In another study there was no difference between nonionic and ionic contrast agents in terms of their propensity to produce nephrotoxicity.56 Close attention was paid to the state ofhydration in both ofthese studies and many patients received intravenous hydration. Patients with myeloma are particularly susceptible to contrast as illustrated by a report of ARF occurring in a patient with this condition who received oral contrast for cholecystography.5 (c) ARF in bone marrow transplantation A growing number of patients with haematological malignancies develop ARF, and dialysis requiring ARF has recently been reported in 24% of bone marrow transplanted patients.58 Its development was presaged by jaundice, weight gain, amphotericin B usage, septicaemia, and hypotension. Its prognosis is poor with a mortality of 84%.
(d) Haemolytic uraemic syndrome In the epidemic form of haemolytic uraemic syndrome in children a diarrhoeal prodrome preceeds the development of the disease. A particular strain of Escherichia coli (serotype 01 57:H7) is identifiable in the stool of these children. In other parts of the world, for example in South America and the Indian Sub-continent, Salmonella and Shigella have been implicated. These bacterial species produce toxins capable of fixing to and damaging the endothelial cell. In the case of E. coli the toxin is verotoxin. 59 In the haemolytic uraemic syndrome and presumably also in related conditions such as thrombotic thrombocytopenic purpura, post-partum acute renal failure, accelerated phase hypertension and the scleroderma crisis, endothelial damage leads to a thrombotic microangiopathy and the development ofthe well known clinical and biochemical features of these diseases. In most cases treatment is supportive with control of blood pressure and early dialysis. The infusion of large volumes of fresh frozen plasma (but not human albumin), either by simple infusion or by plasma exchange in the oliguric patient, will turn off the microangiopathy and may preserve renal function.' Prostacyclin infusion may be of additional benefit although proof is lacking. The difficulty lies in deciding which cases require aggressive treatment and which will recover with simple supportive therapy only. In general older children and adults and isolated or sporadic cases without a diarrhoeal prodrome probably warrant full therapy. How fresh frozen plasma works is not clear. Suggestions include supplying missing substrates for PGI2 synthesis, restoration ofenzymes capable of breaking up abnormal factor IIX von Willebrand macromolecular complexes and supplying enzymes which stabilize the complex clotting mechanisms.
(e) Hepato-renal syndrome (HRS) The hepatorenal syndrome gets little discussion in many books as it heralds end stage liver disease and cannot easily be pharmacologically reversed. However, with the advent of liver transplantation renal physicians will be asked to support more of these patients pending liver transplantation, particularly if the hopes raised by FK506 as a new immunosuppressive agent are fully substantiated. The hepato-renal syndrome develops in patients with pronounced systemic vasodilatation with systemic as well as portal shunting of blood.6' Systemic vascular resistance is markedly reduced. The acute renal failure occurs with intense intrarenal vasoconstriction yet with marked peripheral vasodilatation. The vasodilatation, shunting and reduced systemic vascular resistance render the effective arterial blood volume inadequate. This in turn leads to the stimulation of the sympathetic nervous system, the renin-angiotensin-aldosterone system and AVP release. The hepato-renal syndrome may be viewed as an exaggerated attempt to preserve arterial blood volume in a situation where the arterial side of the circulation can never be replete because of the shunts and vasodilatation. What mediates the systemic vasodilatation is unclear although glucagon is a likely contender. The intrarenal vasoconstriction may be multifactorial with angiotensin II, catecholamines, reduced prostaglandins and bradykinin being suggested. Endotoxin, tumour necrosis factor and the recently described endothelial derived relaxing factor and endothelin may all play a role. In the short term, immersion to the neck in water (which expands the intravascular volume without altering its composition) together with a noradrenaline infusion will provoke a diuresis in these patients. 62 Ornithine vasopressin (a vasoconstrictor analogue of AVP) may also be effective.63 (iii) Pathogenesis ofacute tubular necrosis Much recent attention in this area has been focused on the seeming paradox of the kidney's unique susceptibility to hypoxic insult in the face of the undoubted richness of its blood supply. Solutions have concentrated on two main approaches. Firstly, an exploration of the inhomogeneity of oxygen supply and requirements within the kidney and particularly within the medulla, and secondly an examination of the potential role of activated oxygen species in mediating ischaemic and postischaemic injury.
Tubules and vessels of the medulla are distributed in hairpin arrangements to facilitate countercurrent exchange of solutes and allow efficient concentration of urine. Oxygen is able to diffuse directly between arterial and venous limbs of the vasa recta resulting in strikingly low oxygen concentrations in medullary tissues. The osmotic gradient within the medulla is generated by active transport ofsodium chloride by the thick ascending limb of Henle's loop (mTAL) which requires large amounts of energy. The low oxygen content of medullary blood and the constraints on medullary blood flow imposed by the requirement to maintain the concentration gradient ensure that the mTAL always operates on the edge of hypoxia. During an ischaemic insult therefore critical hypoxia leading to selective necrosis of the mTAL readily results and has been demonstrated in many animal models (for review see Brezis').
A reduction of the oxygen requirement of the mTAL by pharmacological blockade (e.g. with frusemide) or by reducing GFR (e.g. by hyperoncotic albumin infusion) has been shown to prevent mTAL damage. Regulatory mechanisms to protect the vulnerable mTAL from ischaemic injury have been hypothesized. Adenosine, a product of high energy phosphate metabolism, accumulates in ischaemic conditions and down-regulates tranport in mTAL, increases medullary oxygenation by improving vasa recta flow and reduces GFR by augmenting tubuloglomerular feedback. Prostaglandin E2 also reduces transport in the mTAL and enhances medullary blood flow, and other arachidonic acid derivatives may have similar effects. The unravelling of these intricate mechanisms may produce viable strategies for treatment and prevention.
Ischaemia and subsequent reperfusion is a potent stimulus to the production of free radicals,65 the former by the mitochrondrial respiratory mechanism and the latter by oxidation ofhypoxanthine (an end product of high energy phosphate metabolism) by xanthine oxidase, a reaction which yields superoxide. Free radicals damage tissue principally by peroxidation of lipids, with resultant membrane destruction. The mTAL is clearly ripe for free radical induced damage.' It is exquisitely vulnerable to ischaemia and its high energy requirement ensures a rich substrate of hypoxanthine for free radical production on reperfusion. There is some experimental evidence to suggest that free radical-induced damage may be a factor in ARF, since glutathione, an endogenous free radical scavenger, and desferrioxamine both protect against postischaemic injury in the rat.67"' niques are simplicity, the lack of sophisticated equipment, smooth control of fluid balance and little cardiovascular instability. CAVH is seldom adequate for renal replacement in hypercatabolic patients achieving a creatinine clearance of 10 Over the last few years experience has grown with the ANCA assay (anti-neutrophil cytoplasmic antibody). The test is of diagnostic value and also helps to assess disease activity in both microscopic polyarteritis and Wegener's granulomatosis.99"'00 " Human antibodies to the Wegener's antigen and a monoclonal antibody directed against a highly purified preparation of this antigen react specifically with the epithelial and endothelial cells but not mesangial cells from cultured human glomeruli. This suggests a possible aetiological role for ANCA as the antibody appears cytotoxic in cell culture."'' Duration of immunosuppressive therapy is an unresolved and difficult question. In diseases with clear clinical and laboratory indices of activity treatment can be tailored to activity and in some cases may be safely stopped. However relapses can occur, cannot always be predicted and may be fulminating.'02"103 Careful and prolonged follow-up is clearly required.
(ii) Crescentic glomerulonephritis Focal necrotizing and crescentic glomerulonephritis frequently occur in the setting of one of the multisystem vasculitides, but may appear as a primary or idiopathic form of glomerulonephritis. However, with the introduction of reliable assays for the multisystem vasculitides such as anti-double strand DNA antibody for SLE and the ANCA antibody assay, the diagnosis of primary or idiopathic glomerulonephritis is being made less frequently.'04 105 Clinically these lesions present either as the nephritic or nephrotic syndrome with a rapid deterioration to acute renal failure such that patients may become dialysis-dependent in a few weeks. Awareness of the rapidity of the evolution of the disease is important so that an early renal biopsy is performed.
(iii) Henoch-Schonleinpurpura (HSP) HSP can be a fulminating severe multisystem disorder which may be associated with the dire complication of gut vasculitis. As might be expected the patients with more than 50% of the glomeruli affected by crescents do particularly badly. Nevertheless the prognosis is generally assumed to be good particularly in children with 40% or more entering a full remission."' Prognosis in adults is less clear but considerably poorer with only 25% of adult patients preserving renal function."2 In such patients with severe disease treatment would be along the lines suggested for microscopic polyarteritis.
(iv) The role ofplasma exchange As a group, whether so called, idiopathic or associated with a multisystem vasculitis, these conditions do respond well to immunosuppression."'0 The role of plasma exchange is still controversial.'07 However, what is clear is that for the treatment of non-oliguric anti-GBM antibodymediated disease plasma exchange remains the treatment of choice. This is particularly so in the case oflung haemorrhage irrespective ofwhat renal function is doing. Relapses after adequate initial therapy for Goodpasture's disease are rare. [108] [109] [110] For non-anti-GBM antibody-mediated crescentic or focal necrotizing GN, immunosuppression with steroids and cyclophosphamide is probably sufficient. Plasma exchange, however, may be of benefit, particularly in fulminating cases and in cases in which the patients rapidly become dialysis dependent.'" There are many reports of patients having been successfully treated so that renal function recovers and dialysis may be withdrawn in patients with the multisystem vasculitides. This is a rarity in Goodpasture's disease.
(v) Lupus anticoagulant
Arterial and venous thromboses may occur in patients with SLE or lupus-like diseases. These lesions affect many organs including the kidney, skin, heart, eyes and central nervous system. A history of recurrent spontaneous abortions is common. These clinical features are associated with the lupus anticoagulant which is an autoantibody to complex lipoprotein antigens on platelets and coagulation factors. These antibodies are responsible for the biological false positive test for syphilis (VDRL), anti-cardiolipin antibodies and the production of a prolonged PTTK. 
Urinary tract infection
It is apparent that 30% of all women presenting with bacterial infection of the bladder have 'low colony count' bacteriuria (l02-l0I cfu/ml). The evidence for an aetiological role for such low counts in women with acute dysuria includes; isolation of E. coli from suprapubic aspirates, the occurrence of pyuria in 90% of cases, the association with vaginal colonization with E. coli in about 90% of cases, the similarity of bacterial virulence properties to those found in typical cases (i.e. those with > IO' cfu), the similarity of presentation to that in typical cases.'"5
The incidence of occult upper tract infection in patients presenting with acute cystitis, based on localization tests such as the antibody coated bacteria test or the bladder washout test, is 10-50%. The presence of occult upper tract infection has important implications for therapy."5 E. coli urinary tract infections in young women are usually preceded by vaginal colonization, and women with recurrent infections appear to have more frequent vaginal colonization than rarely infected women, often due to increased susceptibility of their vaginal and uroepithelial cells to adhering E. coli. Two host factors may be important in determining this increased susceptibility, the use of diaphragm and spermicide contraception"' and blood group secretor status."6 A number of bacterial virulence factors have been described, the most important of which are fimbrial adhesins (Gal-Gal and P), haemolysin, and aerobactin. Strains of E. coli with multiple virulence factors are more commonly found in upper tract infection; those in cystitis more commonly resemble faecal strains."5 "7
Single dose therapy for urinary tract infection particularly with amoxycillin is generally less effective than 10 day treatment, though the rates of adverse reactions are much lower. Most failures of single dose therapy manifest as early reinfection from the vaginal reservoir rather than persistent upper tract infection. This highlights the importance of the drugs effects on the vaginal flora compared with its initial effect clearing bacteriuria. 15 Urinary isolates from patients with asympto- An interesting aspect ofthis treatment is its effect on renal function. There is little clinical data available in this area and no long term follow-up studies. Experimental work though has shown the acute effects of interstitial haemorrhage and chronic effects of interstitial fibrosis in dogs, rabbits and pigs.'2' 123 In humans increased levels of urinary enzymes were found acutely,'24 and in another study transient nephrotic range proteinuria occurred without a change in creatinine clearance. Proteinuria returned to normal within 3 to 6 months. '25 Chronic renal failure (i) Uraemic syndrome
The quest for the uraemic toxin continues with the description of a number of new contenders'26"27 and re-exploration of well established ones.'28"29 A vast literature is accumulating on the role of parathyroid hormone as a uraemic toxin, much of it emanating from the originator ofthe concept and collaborators.'30 It is clear that parathyroid hormone is toxic (Table IV) , however almost all of this data is from experimental work, much of it carried out in vitro and evidence for major clinically relevant effects of parathyroidectomy in uraemia other than on mineral and skeletal metabolism remains scanty.'3' -134
(ii) Acquired cystic disease Acquired cystic disease in end stage kidneys was described fairly recently. ' 35 It was originally con- The treatment of renal bone disease also contains controversial areas. Treatment of hyperphosphataemia is a major weapon aimed at preventing hyperparathyroidism and extraskeletal calcification. Aluminium containing agents are highly effective phosphate binders'" but have lately been incriminated as a major factor in the pathogenesis of aluminium toxicity. There is much recent literature centred on the search for a suitable alternative. Dietary restriction is unnecessarily prohibitive, and dialysis techniques too ineffecient, so an alternative phosphate binder is required. Calcium carbonate is the most studied.'47 It is effective but some patients require additional aluminium hydroxide for optimal phosphate control.' Some patients experienced mild gastrointestinal symptoms but the major side effect is hypercalcaemia carrying with it the spectre of increased extraskeletal calcification with long term use. This is a particular risk in patients taking vitamin D compounds. To offset these risks some studies have been performed in which oral calcium carbonate usage has been combined with a reduction in dialysate calcium concentration,'49-'5' with generally satisfactory results.
Reports of the phosphate binding potential of salts of heteropolyuronic acid were initially received with enthusiasm,'52,' but there has been very little clinical experience since, IM and more data is required. Calcium citrate is undoubtedly effective but carries the risk of hypercalcaemia.'"5 A further major risk is the potentiation ofaluminium absorption which citrate undeniably causes.'56 Calcium acetate has recently been advocated'"7 and use of calcium salts of ketoanalogues might kill two birds with one stone. '47 The other major device which has been used to control serum phosphate levels in uraemia is the combination ofmagnesium containing compounds which are less efficient phosphate binders than aluminium or calcium,'46'58 and low magnesium dialysate levels to prevent toxic accumulation of magnesium. This rather cumbersome approach seems to work at least when magnesium carbonate is used. '58 Treatment of established hyperparathyroidism with I alpha-hydroxylated vitamin D compounds is well accepted and is effective at least in the short term, and prevention of established disease by treatment with low doses of these agents seems possible without the previously feared threat of accelerated progression of the underlying renal failure, provided monitoring is meticulous. 159 In the long term though many patients progress to develop hypercalcaemic hyperparathyroidism and treatment then becomes difficult (Figure 8 ). Intermittent intravenous treatment with 1,25-(OH)2D3 has been effective in suppressing parathyroid hormone secretion and improving bone disease without troublesome hypercalcaemia in many of these patients in whom parathyroidectomy would otherwise have been inevitable."W The reason for the superiority of the intravenous over the oral route is uncertain. Intravenous administration may cause less stimulation of intestinal calcium absorption, and may provide a more potent suppressive stimulus to the parathyroid gland by virtue of the higher plasma levels associated with intravenous pulse administration. It has certainly been shown that the intravenous treatment increases the sensitivity of the gland to the ambient calcium level. '6' Parathyroidectomy, however, is still frequently required, and the operation of choice is again in doubt. Over the last few years total parathyroidectomy with autotransplantation of parathyroid fragments into an accessible forearm muscle has become popular, the perceived benefit being mainly the accessibility of the grafted tissue should hypercalcaemia recur. Recently it has become clear that total parathyroidectomy is incomplete in most cases and leaves fragments of parathyroid tissue in the neck which can again become hyperplastic. 162"163 This creates a considerable diagnostic dilemma if hypercalcaemia recurs after autotransplantation and also speaks volumes about the progressive nature of hyperparathyroidism in uraemia.
(iv) Aluminium toxicity
The accumulation within the body of uraemic patients of large amounts of aluminium is associated with severe dysfunction of many organ systems producing a severe dysplastic bone disease, disabling encephalopathy and an inappropriate anaemia. The disease was originally considered to be caused solely by aluminium accumulation from water used for dialysis but now an 'endemic' form of the disease has been identified and attributed to aluminium accumulated by ingestion ofaluminium- The demonstration of toxic effects at low levels of accumulation reinforces the need for precise, readily available means of diagnosis. Unfortunately serum levels both before and after desferrioxamine infusion are unreliable, correlating poorly with stainable bone stores which remains the only available means for definitive diagnosis at present. ' damage'"' and microalbuminuria predicts vascular disease in non-diabetics'9' and increased mortality in elderly patients. '92 There is no doubt that antihypertensive treatment reduces the rate of progression of established diabetic nephropathy. '93"94 Recently it has been suggested that treatment with angiotensin converting enzyme inhibitors may confer specific benefits, making them the antihypertensive agents of choice in treating hypertension in diabetes. These agents antagonize the vasoconstrictive effects ofangiotensin II on the efferent arteriole, thus lowering intraglomerular capillary as well as systemic pressures. This effect is thought to be potentially beneficial since raised intraglomerular capillary pressure may be an important determinant in the progression of renal disease.'95 Limited studies have so far failed to demonstrate any benefits of these agents over conventional antihypertensive treatment.'96 However, angiotensin converting enzyme inhibitors have been shown to prevent progression to clinical nephrophy in normotensive microalbuminuric diabetics'97 and prevent progressive proteinuria in normotensive diabetics with established nephropathy.' 98 Short term protein restriction in normoalbuminuric diabetics has been shown to reduce hyperfiltration'" and current theories on the mechanisms of progression of renal failure suggest When renal function has deteriorated to a certain critical point then further progression to end-stage disease is inevitable, no matter what the initiating insult was, and even if it has ceased operating. The characteristic renal lesion is progressive glomerulosclerosis, associated with declining GFR, and increasing hypertension and proteinuria.
Theories to explain this sequence of events usually suggest an initiating insult causing renal damage and nephron loss, as a result of which changes occur, intrarenally or systemically, either as a direct result of the previous injury or as an adaptive response (Table V) . These changes, either directly or operating through a variety of postulated amplification mechanisms cause further renal damage, thus perpetuating the process and rendering it self-sustaining.
Explanations based on the adaptive haemodynamic changes which accompany nephron loss have dominated until recently. A decade ago it was demonstrated that in many models ofchronic renal failure single nephron plasma flow and GFR were elevated. It was argued that these adaptive changes to nephron loss were initially beneficial but in the long term promoted glomerulosclerosis and Nephron loss in many situations causes an increase in glomerular size in addition to hyperperfusion and a strong correlation between the degree of glomerular hypertrophy and subsequent development of glomerulosclerosis has been noted.07 However, glomerular hypertrophy and glomerulosclerosis can also apparently be dissociated, particularly in situations in which severe systemic hypertension does not develop (see reference 206 for review). There is good evidence, however, that systemic hypertension accelerates the decline in renal function in many human nephropathies and experimental evidence suggests that transmission of the systemic pressure to the glomerulus by loss of autoregulation and afferent arteriolar dilatation is an important prerequisite (see reference 208 for review).
Abnormalities of lipid metabolism also occur in patients with renal disease particularly those in which there is heavy proteinuria, and it has been suggested that elevated plasma lipid levels in these situations may exacerbate renal damage.39 Indeed glomerulosclerosis has been likened to atherosclerosis.210 There is some experimental evidence to support these contentions,21' but clinical evidence is lacking.
Events occurring within the tubules as a response to nephron loss have also been suggested as a possible factor leading to progression. There is a remarkable increase in oxygen consumption per nephron, mainly as a result of increased sodium reabsorption. It is postulated that this increased activity is ultimately damaging perhaps by provoking increased generation of free radicals,212 though there is little direct evidence for this. In summary, none of these proposed mechanisms, even the most well established, appears to operate exclusively and it appears likely that multiple factors are involved, possibly different combinations of factors will transpire to be important in different disease processes.
Only antihypertensive treatment is ofproven use (ii) Erythropoietin
The clinical use of recombinant human erythropoietin (r-HuEPO) has transformed the lives of many anaemic dialysis patients.222 224 Many of the symptoms attributed to uraemia have resolved. Libido returns, appetite and weight increase and growth in children is improved and energy and well being are dramatically restored. The major complication that has emerged from these early studies is The increasing range ofmonoclonal antibodies is being applied to renal transplantation. So far no individual or cocktail is ideal either for the treatment of rejection or for prophylaxis. Antibodies to CD3, CD7, CD25 and CD4 have all been used with varying success.234 An exciting development in molecular biology is the ability to chimerize these molecules so that the majority of the molecule is human protein except for the antigen binding site which is murine. Preliminary studies with a chimeric human/mouse anti-CD7 antibody23' shows that these reagents are non-immunogenic, well tolerated and have immunosuppressive properties. Rapid developments are expected in this field and more reagents will be chimerized soon so that clinical experience with these remarkable molecules will enlarge rapidly.
